Table of Content

Chapter 1: Executive summary

Chapter 2: Socio-economic indicators

Chapter 3: Introduction
3.1. Market definition and structure

Chapter 4: Market overview
4.1. Pharmaceutical export market in India – An overview
4.2. Export of pharmaceutical products (HS Code: 30) (FY 2019 to FY 2022)
4.3. Country-wise export of pharmaceutical products (HS Code: 30)
– by value (FY 2020, FY 2021 & FY 2022)

Chapter 5: COVID-19 impact assessment
5.1. Overview
5.1.1. Positive impact
5.1.2. Negative impact
5.2. Post-pandemic scenario

Chapter 6: Trade analysis

6.1. Export of pharmaceutical products
6.1.1. Commodity-wise export- Based on value
6.1.2. Country-wise export- Based on value
6.1.3. Other exports- Based on value

Chapter 7: Market influencers
7.1. Market drivers
7.2. Market challenges

Chapter 8: Government initiatives

8.1 Government initiatives

Chapter 9: Competitive landscape
9.1. Alkem Laboratories Limited
? Company information
? Business description
? Products/services
? Key people
? Financial snapshot
? Key business segments
? Key geographic segments
Note: Financial information covered only for public companies
9.2. Aurobindo Pharma Limited
9.3. Cipla Limited
9.4. Divi’s Laboratories Limited
9.5. Dr. Reddy’s Laboratories Limited
9.6. Glenmark Pharmaceuticals Limited
9.7. Lupin Limited
9.8. Sun Pharmaceutical Industries Limited
9.9. Torrent Pharmaceuticals Limited
9.10. Zydus Lifesciences Limited

Chapter 10: Recent developments
10.1. Recent developments
Chapter 11: Appendix
11.1. Research methodology
11.2. About Netscribes
11.3. Disclaimer